Alere Inc (ALR)

50.99
0.00 (0.00)
NYSE : Health Care
Prev Close 50.99
Open 50.99
Day Low/High 50.98 / 51.00
52 Wk Low/High 34.41 / 51.00
Volume 1.22M
Avg Volume 1.88M
Exchange NYSE
Shares Outstanding 87.58M
Market Cap 4.47B
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
Alere Analytics Launches Electronic Laboratory Reporting (ELR) Solution To Help Hospitals Automate Public Health Submissions And Satisfy Meaningful Use Requirements

Alere Analytics Launches Electronic Laboratory Reporting (ELR) Solution To Help Hospitals Automate Public Health Submissions And Satisfy Meaningful Use Requirements

Alere Analytics, an Alere subsidiary specializing in healthcare analytics and clinical decision support (CDS) technology, today announced the availability of its Electronic Laboratory Reporting (ELR) Solution to ...

Coppersmith Capital Issues Statement Regarding Alere Annual Meeting

Coppersmith Capital Issues Statement Regarding Alere Annual Meeting

Coppersmith Capital Management, LLC today issued the following statement in response to the apparent election of Alere Inc.

Coppersmith Capital Thanks Stockholders For Their Support To Date And Common Sense Rejection Of Alere’s Desperate Attempts To Preserve The Status Quo

Coppersmith Capital Thanks Stockholders For Their Support To Date And Common Sense Rejection Of Alere’s Desperate Attempts To Preserve The Status Quo

Coppersmith Capital Management, LLC and the other participants in its proxy solicitation (collectively, “Coppersmith”), the fourth-largest stockholder of Alere, Inc.

Coppersmith Capital Exposes Desperate Actions By Alere To Try And Preserve Status Quo

Coppersmith Capital Exposes Desperate Actions By Alere To Try And Preserve Status Quo

Coppersmith Capital Management, LLC and the other participants in its proxy solicitation (collectively, “Coppersmith”), the fourth-largest stockholder of Alere, Inc.

Coppersmith Capital Issues Letter To Alere Inc. Stockholders

Coppersmith Capital Issues Letter To Alere Inc. Stockholders

Coppersmith Capital Management, LLC and the other participants in its proxy solicitation (collectively, “Coppersmith”), the fourth-largest stockholder of Alere, Inc.

Both Leading Proxy Advisors, ISS And Glass Lewis, Recommend A Vote On The BLUE Proxy Card To Elect Coppersmith’s Nominees To Alere’s Board

Both Leading Proxy Advisors, ISS And Glass Lewis, Recommend A Vote On The BLUE Proxy Card To Elect Coppersmith’s Nominees To Alere’s Board

Coppersmith Capital Management, LLC (“Coppersmith”) today announced that both Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co.

'Mad Money' Lightning Round: I Like Raymond James Financial

'Mad Money' Lightning Round: I Like Raymond James Financial

Don't sell Alere but don't buy Green Mountain Coffee Roasters, Cramer advised.

Cramer's 'Mad Money' Recap: Maximum Gains From Minimum Competition

Cramer's 'Mad Money' Recap: Maximum Gains From Minimum Competition

Competition matters, and those in cut-throat industries got pummeled today, Cramer said.

Coppersmith Capital Files Detailed Presentation On Alere Inc

Coppersmith Capital Files Detailed Presentation On Alere Inc

Coppersmith Capital Management, LLC (“Coppersmith Capital”) today announced that it has filed a comprehensive presentation detailing its strategic plan to improve performance and enhance stockholder value at ...

Coppersmith Capital Files Definitive Proxy Materials To Elect Three Highly-Qualified Candidates To Alere’s Board And Sends Letter To Alere Stockholders

Coppersmith Capital Files Definitive Proxy Materials To Elect Three Highly-Qualified Candidates To Alere’s Board And Sends Letter To Alere Stockholders

Coppersmith Capital Management, LLC (“Coppersmith Capital”) and the other participants in its proxy solicitation (collectively, “Coppersmith”), the fourth-largest stockholder of Alere, Inc.

4 Health Care Stocks Rising on Major Volume

4 Health Care Stocks Rising on Major Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Analysts' Actions: AAPL V KSS PHM AMGN

Analysts' Actions: AAPL V KSS PHM AMGN

Here are today's top research calls.

Alere's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Alere's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Alere's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Alere Stock Hits New 52-Week Low (ALR)

Alere Stock Hits New 52-Week Low (ALR)

Alere (NYSE:ALR) hit a new 52-week low Monday as it is currently trading at $17.73, below its previous 52-week low of $17.76 with 218,734 shares traded as of 2:13 p.m. ET. Average volume has been one million shares over the past 30 days.

Alere Inc (ALR): Today's Featured Health Services Winner

Alere Inc (ALR): Today's Featured Health Services Winner

Alere was a winner within the health services industry, rising 14 cents (0.8%) to $18.60 on heavy volume.

Alere Stock Gaps Down On Today's Open (ALR)

Alere Stock Gaps Down On Today's Open (ALR)

Shares of Alere (NYSE:ALR) were gapping down Friday morning with an open price 13.6% lower than Thursday's closing price. The stock closed at $22.30 yesterday and opened today's trading at $19.26.

Preliminary Results Of Prospective Trial Suggest Warfarin May Be A Safer Option For Patients Than Alternative Therapies

Preliminary Results Of Prospective Trial Suggest Warfarin May Be A Safer Option For Patients Than Alternative Therapies

Today, at the 2012 Thrombosis and Hemostasis Summit of North America, Alere Inc.

Analysts' Actions: AEO, ANF, COST, HOLX

Analysts' Actions: AEO, ANF, COST, HOLX

Here are today's top research calls.

Alere's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Alere's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Alere's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Alere's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Alere's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Alere's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Alere™ Rapid Flu Test Receives CLIA Waiver From FDA

Alere™ Rapid Flu Test Receives CLIA Waiver From FDA

Alere Inc. (NYSE:ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, received confirmation that The U.

7 U.S. Stock Picks for 2012 From Addison Capital

7 U.S. Stock Picks for 2012 From Addison Capital

The private-wealth firm says investors ought to be more optimistic about the likes of Visa and Qualcomm.

Alere Inc Stock Upgraded (ALR)

Alere Inc Stock Upgraded (ALR)

Alere Inc (NYSE:ALR) has been upgraded by TheStreet Ratings from a sell to hold.

This Image Is Part Of The Alere 'Make (+) More Positive' Effort, Launched Today At The US Conference On AIDS In Chicago. See Thousands Of Submissions At Www.morepositive.com. (Graphic: Business Wire)

This Image Is Part Of The Alere 'Make (+) More Positive' Effort, Launched Today At The US Conference On AIDS In Chicago. See Thousands Of Submissions At Www.morepositive.com. (Graphic: Business Wire)

Alere Inc. (NYSE: ALR) will launch its Make (+) More Positive campaign at the United States Conference on AIDS at the Sheraton Chicago Hotel & Towers on November 10-13.

3 Health Care Stocks That Could Gain 50% or More

3 Health Care Stocks That Could Gain 50% or More

Each of these companies look to have at least 50% upside, and are poised for solid annual results in 2012 and beyond.

Alere's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Alere's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Alere's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Alere Stock Hits New 52-Week Low (ALR)

Alere Stock Hits New 52-Week Low (ALR)

Alere Inc (NYSE:ALR) hit a new 52-week low Tuesday as it is currently trading at $18.26, below its previous 52-week low of $18.46 with 79,644 shares traded as of 10:36 a.m. ET. Average volume has been one million shares over the past 30 days.

Alere Stock Hits New 52-Week Low (ALR)

Alere Stock Hits New 52-Week Low (ALR)

Alere Inc (NYSE:ALR) hit a new 52-week low Monday as it is currently trading at $20.89, below its previous 52-week low of $21.06 with 100,853 shares traded as of 10:01 a.m. ET. Average volume has been one million shares over the past 30 days.

Alere Stock Hits New 52-Week Low (ALR)

Alere Stock Hits New 52-Week Low (ALR)

Alere Inc (NYSE:ALR) hit a new 52-week low Friday as it is currently trading at $21.65, below its previous 52-week low of $21.67 with 347,393 shares traded as of 2:26 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.